RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Lucira Health Stock

Lucira Health Revenue 2024

Lucira Health Revenue

128.75 M USD

Ticker

LHDXQ

ISIN

US54948U1051

In 2024, Lucira Health's sales reached 128.75 M USD, a -43.76% difference from the 228.92 M USD sales recorded in the previous year.

The Lucira Health Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2023e128.7514,11
2022e228.927,93
202193.0619,52
20200.27-621,56

Lucira Health Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Lucira Health, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Lucira Health from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Lucira Health’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Lucira Health. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Lucira Health’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Lucira Health’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Lucira Health’s growth potential.

Lucira Health Revenue, EBIT and net profit per share

DateLucira Health RevenueLucira Health EBITLucira Health Net Income
2023e128.75 M USD-32.19 M USD-24.25 M USD
2022e228.92 M USD-156.81 M USD-9.62 M USD
202193.06 M USD-57.2 M USD-64.83 M USD
2020269,000 USD-31.93 M USD-37.35 M USD

Lucira Health stock margins

The Lucira Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Lucira Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Lucira Health.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Lucira Health's sales revenue. A higher gross margin percentage indicates that the Lucira Health retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Lucira Health's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Lucira Health's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Lucira Health's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Lucira Health. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Lucira Health's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Lucira Health Margin History

Lucira Health Gross marginLucira Health Profit marginLucira Health EBIT marginLucira Health Profit margin
2023e19.52 %-25 %-18.84 %
2022e19.52 %-68.5 %-4.2 %
202119.52 %-61.47 %-69.67 %
2020-621.56 %-11,868.03 %-13,884.02 %

Lucira Health Aktienanalyse

What does Lucira Health do?

Lucira Health is an American company specializing in the development and manufacturing of diagnostic devices and kits. It was founded in 2013 and is headquartered in Emeryville, California. The company was founded by Dr. Erik Engelson and Dr. Jessie Zhou, both of whom have experience in developing molecular diagnostic tests. Lucira Health initially provided research and development services for other companies before deciding to develop its own products. In 2018, the company won first place in the XPRIZE Rapid-Response COVID-19 competition and received a $5 million award for the development of a rapid COVID-19 test. Lucira Health's business model focuses on the development and manufacturing of diagnostic devices and kits. The company works closely with other organizations to develop faster, more effective, and cost-efficient tests. It also utilizes partnerships and licensing agreements to market its devices and tests. Lucira Health has two main divisions: molecular diagnostics and point-of-care diagnostics. In molecular diagnostics, the company offers a range of tests specifically designed for molecular diagnostics, including tests for diagnosing infectious diseases such as COVID-19, influenza, and hepatitis B and C. In point-of-care diagnostics, Lucira Health specializes in the development of point-of-care diagnostic devices that are designed to deliver fast and accurate test results within minutes. The company has developed the first FDA-approved COVID-19 test kit that can be used at home. The test kit provides results within 30 minutes and requires only a nasal swab. In addition to its diagnostic products, the company has also developed a platform that allows users to submit and track their test results online. In conclusion, Lucira Health is a company focused on the development of diagnostic devices and kits. With its emphasis on molecular and point-of-care diagnostics, the company has developed a range of tests that can be used to diagnose infectious diseases. With its history of collaboration with other organizations and the $5 million award from the XPRIZE Rapid-Response COVID-19 competition, Lucira Health is expected to continue developing innovative products that contribute to the improvement of public health. Lucira Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Lucira Health's Sales Figures

The sales figures of Lucira Health originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Lucira Health’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Lucira Health's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Lucira Health’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Lucira Health stock

How much revenue did Lucira Health generate this year?

Lucira Health has achieved a revenue of 128.75 M USD this year.

How much was the turnover of the company Lucira Health compared to the previous year?

The revenue of Lucira Health has increased by -43.76% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Lucira Health?

The revenue of Lucira Health is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Lucira Health measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Lucira Health so important for investors?

The revenue of Lucira Health is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Lucira Health pay?

Over the past 12 months, Lucira Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Lucira Health is expected to pay a dividend of 0 USD.

What is the dividend yield of Lucira Health?

The current dividend yield of Lucira Health is .

When does Lucira Health pay dividends?

Lucira Health pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Lucira Health?

Lucira Health paid dividends every year for the past 0 years.

What is the dividend of Lucira Health?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Lucira Health located?

Lucira Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Lucira Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Lucira Health from 9/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/16/2024.

When did Lucira Health pay the last dividend?

The last dividend was paid out on 9/16/2024.

What was the dividend of Lucira Health in the year 2023?

In the year 2023, Lucira Health distributed 0 USD as dividends.

In which currency does Lucira Health pay out the dividend?

The dividends of Lucira Health are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Lucira Health

Our stock analysis for Lucira Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lucira Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.